nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—SLC22A5—Dactinomycin—sarcoma	0.565	1	CbGbCtD
Cefadroxil—Infertility—Mitoxantrone—sarcoma	0.0177	0.0407	CcSEcCtD
Cefadroxil—Nephropathy toxic—Mitoxantrone—sarcoma	0.00805	0.0185	CcSEcCtD
Cefadroxil—Nephropathy toxic—Etoposide—sarcoma	0.0067	0.0154	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Thiotepa—sarcoma	0.00566	0.013	CcSEcCtD
Cefadroxil—Prothrombin level increased—Epirubicin—sarcoma	0.00526	0.0121	CcSEcCtD
Cefadroxil—Blood urea increased—Thiotepa—sarcoma	0.00506	0.0116	CcSEcCtD
Cefadroxil—Aplastic anaemia—Dactinomycin—sarcoma	0.00499	0.0115	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Mitoxantrone—sarcoma	0.00489	0.0112	CcSEcCtD
Cefadroxil—Prothrombin level increased—Doxorubicin—sarcoma	0.00486	0.0112	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Thiotepa—sarcoma	0.00447	0.0103	CcSEcCtD
Cefadroxil—Blood urea increased—Mitoxantrone—sarcoma	0.00437	0.01	CcSEcCtD
Cefadroxil—Hepatic failure—Thiotepa—sarcoma	0.00433	0.00993	CcSEcCtD
Cefadroxil—Hepatic failure—Dactinomycin—sarcoma	0.00429	0.00986	CcSEcCtD
Cefadroxil—Lactic dehydrogenase activity increased—Epirubicin—sarcoma	0.00421	0.00968	CcSEcCtD
Cefadroxil—Lactic dehydrogenase activity increased—Doxorubicin—sarcoma	0.0039	0.00895	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Etoposide—sarcoma	0.00385	0.00883	CcSEcCtD
Cefadroxil—Hepatic failure—Vincristine—sarcoma	0.00384	0.00881	CcSEcCtD
Cefadroxil—Swelling—Mitoxantrone—sarcoma	0.00381	0.00874	CcSEcCtD
Cefadroxil—Blood lactate dehydrogenase increased—Epirubicin—sarcoma	0.00371	0.00852	CcSEcCtD
Cefadroxil—Blood creatinine increased—Thiotepa—sarcoma	0.00364	0.00836	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Thiotepa—sarcoma	0.0035	0.00804	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.00347	0.00798	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Dactinomycin—sarcoma	0.00347	0.00798	CcSEcCtD
Cefadroxil—Blood lactate dehydrogenase increased—Doxorubicin—sarcoma	0.00343	0.00788	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Thiotepa—sarcoma	0.00343	0.00787	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Etoposide—sarcoma	0.00321	0.00737	CcSEcCtD
Cefadroxil—Pancytopenia—Thiotepa—sarcoma	0.00319	0.00733	CcSEcCtD
Cefadroxil—Pancytopenia—Dactinomycin—sarcoma	0.00317	0.00727	CcSEcCtD
Cefadroxil—Swelling—Etoposide—sarcoma	0.00317	0.00727	CcSEcCtD
Cefadroxil—Blood creatinine increased—Mitoxantrone—sarcoma	0.00315	0.00722	CcSEcCtD
Cefadroxil—Neutropenia—Dactinomycin—sarcoma	0.00312	0.00716	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Vincristine—sarcoma	0.0031	0.00713	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Mitoxantrone—sarcoma	0.00302	0.00694	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Mitoxantrone—sarcoma	0.00296	0.0068	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00295	0.00677	CcSEcCtD
Cefadroxil—Pancytopenia—Vincristine—sarcoma	0.00283	0.0065	CcSEcCtD
Cefadroxil—Agranulocytosis—Thiotepa—sarcoma	0.0028	0.00642	CcSEcCtD
Cefadroxil—Neutropenia—Vincristine—sarcoma	0.00279	0.0064	CcSEcCtD
Cefadroxil—Agranulocytosis—Dactinomycin—sarcoma	0.00278	0.00637	CcSEcCtD
Cefadroxil—Pancytopenia—Mitoxantrone—sarcoma	0.00276	0.00633	CcSEcCtD
Cefadroxil—Neutropenia—Mitoxantrone—sarcoma	0.00271	0.00623	CcSEcCtD
Cefadroxil—Haemoglobin—Thiotepa—sarcoma	0.0027	0.00621	CcSEcCtD
Cefadroxil—Haemorrhage—Thiotepa—sarcoma	0.00269	0.00618	CcSEcCtD
Cefadroxil—Drowsiness—Mitoxantrone—sarcoma	0.00259	0.00594	CcSEcCtD
Cefadroxil—Erythema multiforme—Dactinomycin—sarcoma	0.00252	0.0058	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00252	0.00577	CcSEcCtD
Cefadroxil—Cramp muscle—Etoposide—sarcoma	0.00252	0.00577	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Etoposide—sarcoma	0.00246	0.00566	CcSEcCtD
Cefadroxil—Agranulocytosis—Mitoxantrone—sarcoma	0.00241	0.00554	CcSEcCtD
Cefadroxil—Haemoglobin—Mitoxantrone—sarcoma	0.00233	0.00536	CcSEcCtD
Cefadroxil—Haemorrhage—Mitoxantrone—sarcoma	0.00232	0.00533	CcSEcCtD
Cefadroxil—Tension—Thiotepa—sarcoma	0.0023	0.00528	CcSEcCtD
Cefadroxil—Pancytopenia—Etoposide—sarcoma	0.00229	0.00526	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Epirubicin—sarcoma	0.00228	0.00524	CcSEcCtD
Cefadroxil—Nervousness—Thiotepa—sarcoma	0.00227	0.00522	CcSEcCtD
Cefadroxil—Creatinine increased—Epirubicin—sarcoma	0.00227	0.0052	CcSEcCtD
Cefadroxil—Neutropenia—Etoposide—sarcoma	0.00226	0.00518	CcSEcCtD
Cefadroxil—Vaginal inflammation—Epirubicin—sarcoma	0.00216	0.00495	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Epirubicin—sarcoma	0.00216	0.00495	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00213	0.0049	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Doxorubicin—sarcoma	0.00211	0.00484	CcSEcCtD
Cefadroxil—Creatinine increased—Doxorubicin—sarcoma	0.0021	0.00481	CcSEcCtD
Cefadroxil—Vaginal infection—Epirubicin—sarcoma	0.00204	0.00468	CcSEcCtD
Cefadroxil—Blood urea increased—Epirubicin—sarcoma	0.00204	0.00468	CcSEcCtD
Cefadroxil—Convulsion—Thiotepa—sarcoma	0.00203	0.00466	CcSEcCtD
Cefadroxil—Aplastic anaemia—Epirubicin—sarcoma	0.00202	0.00465	CcSEcCtD
Cefadroxil—Agranulocytosis—Etoposide—sarcoma	0.00201	0.00461	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Doxorubicin—sarcoma	0.002	0.00458	CcSEcCtD
Cefadroxil—Vaginal inflammation—Doxorubicin—sarcoma	0.002	0.00458	CcSEcCtD
Cefadroxil—Arthralgia—Thiotepa—sarcoma	0.00199	0.00458	CcSEcCtD
Cefadroxil—Blood urea increased—Doxorubicin—sarcoma	0.00188	0.00433	CcSEcCtD
Cefadroxil—Vaginal infection—Doxorubicin—sarcoma	0.00188	0.00433	CcSEcCtD
Cefadroxil—Aplastic anaemia—Doxorubicin—sarcoma	0.00187	0.0043	CcSEcCtD
Cefadroxil—Thrombocytopenia—Thiotepa—sarcoma	0.00187	0.0043	CcSEcCtD
Cefadroxil—Vertigo—Vincristine—sarcoma	0.00187	0.00428	CcSEcCtD
Cefadroxil—Thrombocytopenia—Dactinomycin—sarcoma	0.00186	0.00426	CcSEcCtD
Cefadroxil—Erythema multiforme—Etoposide—sarcoma	0.00183	0.00419	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Epirubicin—sarcoma	0.0018	0.00413	CcSEcCtD
Cefadroxil—Convulsion—Vincristine—sarcoma	0.0018	0.00413	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Epirubicin—sarcoma	0.00179	0.00411	CcSEcCtD
Cefadroxil—Convulsion—Mitoxantrone—sarcoma	0.00175	0.00402	CcSEcCtD
Cefadroxil—Hepatic failure—Epirubicin—sarcoma	0.00174	0.004	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00174	0.004	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00173	0.00397	CcSEcCtD
Cefadroxil—Arthralgia—Mitoxantrone—sarcoma	0.00172	0.00395	CcSEcCtD
Cefadroxil—Somnolence—Thiotepa—sarcoma	0.0017	0.0039	CcSEcCtD
Cefadroxil—Anaphylactic shock—Vincristine—sarcoma	0.00169	0.00389	CcSEcCtD
Cefadroxil—Dyspepsia—Thiotepa—sarcoma	0.00168	0.00386	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.00167	0.00382	CcSEcCtD
Cefadroxil—Thrombocytopenia—Vincristine—sarcoma	0.00166	0.00381	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Doxorubicin—sarcoma	0.00166	0.00381	CcSEcCtD
Cefadroxil—Anaphylactic shock—Mitoxantrone—sarcoma	0.00165	0.00379	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Thiotepa—sarcoma	0.00165	0.00379	CcSEcCtD
Cefadroxil—Muscle spasms—Etoposide—sarcoma	0.00162	0.00371	CcSEcCtD
Cefadroxil—Thrombocytopenia—Mitoxantrone—sarcoma	0.00162	0.00371	CcSEcCtD
Cefadroxil—Hepatic failure—Doxorubicin—sarcoma	0.00161	0.0037	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Thiotepa—sarcoma	0.00156	0.00359	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Dactinomycin—sarcoma	0.00155	0.00356	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Vincristine—sarcoma	0.00154	0.00354	CcSEcCtD
Cefadroxil—Urticaria—Thiotepa—sarcoma	0.00152	0.00349	CcSEcCtD
Cefadroxil—Vertigo—Etoposide—sarcoma	0.00151	0.00347	CcSEcCtD
Cefadroxil—Abdominal pain—Thiotepa—sarcoma	0.00151	0.00347	CcSEcCtD
Cefadroxil—Body temperature increased—Thiotepa—sarcoma	0.00151	0.00347	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.0015	0.00345	CcSEcCtD
Cefadroxil—Body temperature increased—Dactinomycin—sarcoma	0.0015	0.00344	CcSEcCtD
Cefadroxil—Abdominal pain—Dactinomycin—sarcoma	0.0015	0.00344	CcSEcCtD
Cefadroxil—Somnolence—Mitoxantrone—sarcoma	0.00147	0.00337	CcSEcCtD
Cefadroxil—Blood creatinine increased—Epirubicin—sarcoma	0.00147	0.00337	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Vincristine—sarcoma	0.00146	0.00336	CcSEcCtD
Cefadroxil—Convulsion—Etoposide—sarcoma	0.00146	0.00335	CcSEcCtD
Cefadroxil—Dyspepsia—Mitoxantrone—sarcoma	0.00145	0.00334	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00141	0.00324	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00141	0.00324	CcSEcCtD
Cefadroxil—Hypersensitivity—Thiotepa—sarcoma	0.00141	0.00323	CcSEcCtD
Cefadroxil—Hypersensitivity—Dactinomycin—sarcoma	0.0014	0.00321	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Vincristine—sarcoma	0.00139	0.00318	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00138	0.00317	CcSEcCtD
Cefadroxil—Anaphylactic shock—Etoposide—sarcoma	0.00137	0.00315	CcSEcCtD
Cefadroxil—Asthenia—Thiotepa—sarcoma	0.00137	0.00315	CcSEcCtD
Cefadroxil—Asthenia—Dactinomycin—sarcoma	0.00136	0.00312	CcSEcCtD
Cefadroxil—Blood creatinine increased—Doxorubicin—sarcoma	0.00136	0.00312	CcSEcCtD
Cefadroxil—Pruritus—Thiotepa—sarcoma	0.00135	0.0031	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00135	0.0031	CcSEcCtD
Cefadroxil—Thrombocytopenia—Etoposide—sarcoma	0.00134	0.00309	CcSEcCtD
Cefadroxil—Eosinophilia—Epirubicin—sarcoma	0.00134	0.00308	CcSEcCtD
Cefadroxil—Abdominal pain—Vincristine—sarcoma	0.00134	0.00308	CcSEcCtD
Cefadroxil—Body temperature increased—Vincristine—sarcoma	0.00134	0.00308	CcSEcCtD
Cefadroxil—Urticaria—Mitoxantrone—sarcoma	0.00131	0.00301	CcSEcCtD
Cefadroxil—Diarrhoea—Thiotepa—sarcoma	0.00131	0.003	CcSEcCtD
Cefadroxil—Abdominal pain—Mitoxantrone—sarcoma	0.0013	0.003	CcSEcCtD
Cefadroxil—Body temperature increased—Mitoxantrone—sarcoma	0.0013	0.003	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.0013	0.003	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.0013	0.003	CcSEcCtD
Cefadroxil—Diarrhoea—Dactinomycin—sarcoma	0.0013	0.00298	CcSEcCtD
Cefadroxil—Pancytopenia—Epirubicin—sarcoma	0.00129	0.00295	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00128	0.00293	CcSEcCtD
Cefadroxil—Neutropenia—Epirubicin—sarcoma	0.00127	0.00291	CcSEcCtD
Cefadroxil—Dizziness—Thiotepa—sarcoma	0.00126	0.0029	CcSEcCtD
Cefadroxil—Hypersensitivity—Vincristine—sarcoma	0.00125	0.00287	CcSEcCtD
Cefadroxil—Eosinophilia—Doxorubicin—sarcoma	0.00124	0.00285	CcSEcCtD
Cefadroxil—Somnolence—Etoposide—sarcoma	0.00122	0.0028	CcSEcCtD
Cefadroxil—Hypersensitivity—Mitoxantrone—sarcoma	0.00122	0.00279	CcSEcCtD
Cefadroxil—Asthenia—Vincristine—sarcoma	0.00122	0.00279	CcSEcCtD
Cefadroxil—Vomiting—Thiotepa—sarcoma	0.00122	0.00279	CcSEcCtD
Cefadroxil—Drowsiness—Epirubicin—sarcoma	0.00121	0.00277	CcSEcCtD
Cefadroxil—Vomiting—Dactinomycin—sarcoma	0.00121	0.00277	CcSEcCtD
Cefadroxil—Rash—Thiotepa—sarcoma	0.0012	0.00277	CcSEcCtD
Cefadroxil—Dermatitis—Thiotepa—sarcoma	0.0012	0.00276	CcSEcCtD
Cefadroxil—Headache—Thiotepa—sarcoma	0.0012	0.00275	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.0012	0.00275	CcSEcCtD
Cefadroxil—Rash—Dactinomycin—sarcoma	0.0012	0.00275	CcSEcCtD
Cefadroxil—Pancytopenia—Doxorubicin—sarcoma	0.00119	0.00273	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Etoposide—sarcoma	0.00119	0.00272	CcSEcCtD
Cefadroxil—Asthenia—Mitoxantrone—sarcoma	0.00118	0.00272	CcSEcCtD
Cefadroxil—Neutropenia—Doxorubicin—sarcoma	0.00117	0.00269	CcSEcCtD
Cefadroxil—Diarrhoea—Vincristine—sarcoma	0.00116	0.00266	CcSEcCtD
Cefadroxil—Nausea—Thiotepa—sarcoma	0.00114	0.00261	CcSEcCtD
Cefadroxil—Diarrhoea—Mitoxantrone—sarcoma	0.00113	0.00259	CcSEcCtD
Cefadroxil—Nausea—Dactinomycin—sarcoma	0.00113	0.00259	CcSEcCtD
Cefadroxil—Agranulocytosis—Epirubicin—sarcoma	0.00113	0.00259	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Etoposide—sarcoma	0.00112	0.00258	CcSEcCtD
Cefadroxil—Dizziness—Vincristine—sarcoma	0.00112	0.00257	CcSEcCtD
Cefadroxil—Drowsiness—Doxorubicin—sarcoma	0.00112	0.00256	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00111	0.00254	CcSEcCtD
Cefadroxil—Urticaria—Etoposide—sarcoma	0.00109	0.0025	CcSEcCtD
Cefadroxil—Haemoglobin—Epirubicin—sarcoma	0.00109	0.0025	CcSEcCtD
Cefadroxil—Body temperature increased—Etoposide—sarcoma	0.00109	0.00249	CcSEcCtD
Cefadroxil—Abdominal pain—Etoposide—sarcoma	0.00109	0.00249	CcSEcCtD
Cefadroxil—Haemorrhage—Epirubicin—sarcoma	0.00108	0.00249	CcSEcCtD
Cefadroxil—Vomiting—Vincristine—sarcoma	0.00108	0.00247	CcSEcCtD
Cefadroxil—Rash—Vincristine—sarcoma	0.00107	0.00245	CcSEcCtD
Cefadroxil—Dermatitis—Vincristine—sarcoma	0.00107	0.00245	CcSEcCtD
Cefadroxil—Headache—Vincristine—sarcoma	0.00106	0.00244	CcSEcCtD
Cefadroxil—Vomiting—Mitoxantrone—sarcoma	0.00105	0.00241	CcSEcCtD
Cefadroxil—Agranulocytosis—Doxorubicin—sarcoma	0.00104	0.00239	CcSEcCtD
Cefadroxil—Rash—Mitoxantrone—sarcoma	0.00104	0.00239	CcSEcCtD
Cefadroxil—Dermatitis—Mitoxantrone—sarcoma	0.00104	0.00239	CcSEcCtD
Cefadroxil—Headache—Mitoxantrone—sarcoma	0.00103	0.00237	CcSEcCtD
Cefadroxil—Erythema multiforme—Epirubicin—sarcoma	0.00102	0.00235	CcSEcCtD
Cefadroxil—Hypersensitivity—Etoposide—sarcoma	0.00101	0.00232	CcSEcCtD
Cefadroxil—Haemoglobin—Doxorubicin—sarcoma	0.00101	0.00231	CcSEcCtD
Cefadroxil—Nausea—Vincristine—sarcoma	0.00101	0.00231	CcSEcCtD
Cefadroxil—Haemorrhage—Doxorubicin—sarcoma	0.001	0.0023	CcSEcCtD
Cefadroxil—Asthenia—Etoposide—sarcoma	0.000985	0.00226	CcSEcCtD
Cefadroxil—Nausea—Mitoxantrone—sarcoma	0.00098	0.00225	CcSEcCtD
Cefadroxil—Pruritus—Etoposide—sarcoma	0.000971	0.00223	CcSEcCtD
Cefadroxil—Erythema multiforme—Doxorubicin—sarcoma	0.000948	0.00218	CcSEcCtD
Cefadroxil—Diarrhoea—Etoposide—sarcoma	0.000939	0.00216	CcSEcCtD
Cefadroxil—Tension—Epirubicin—sarcoma	0.000925	0.00212	CcSEcCtD
Cefadroxil—Nervousness—Epirubicin—sarcoma	0.000916	0.0021	CcSEcCtD
Cefadroxil—Dizziness—Etoposide—sarcoma	0.000908	0.00208	CcSEcCtD
Cefadroxil—Muscle spasms—Epirubicin—sarcoma	0.000906	0.00208	CcSEcCtD
Cefadroxil—Vomiting—Etoposide—sarcoma	0.000873	0.002	CcSEcCtD
Cefadroxil—Rash—Etoposide—sarcoma	0.000866	0.00199	CcSEcCtD
Cefadroxil—Dermatitis—Etoposide—sarcoma	0.000865	0.00199	CcSEcCtD
Cefadroxil—Headache—Etoposide—sarcoma	0.00086	0.00197	CcSEcCtD
Cefadroxil—Tension—Doxorubicin—sarcoma	0.000856	0.00197	CcSEcCtD
Cefadroxil—Nervousness—Doxorubicin—sarcoma	0.000847	0.00195	CcSEcCtD
Cefadroxil—Vertigo—Epirubicin—sarcoma	0.000847	0.00194	CcSEcCtD
Cefadroxil—Muscle spasms—Doxorubicin—sarcoma	0.000839	0.00193	CcSEcCtD
Cefadroxil—Convulsion—Epirubicin—sarcoma	0.000817	0.00188	CcSEcCtD
Cefadroxil—Nausea—Etoposide—sarcoma	0.000815	0.00187	CcSEcCtD
Cefadroxil—Arthralgia—Epirubicin—sarcoma	0.000803	0.00184	CcSEcCtD
Cefadroxil—Vertigo—Doxorubicin—sarcoma	0.000784	0.0018	CcSEcCtD
Cefadroxil—Anaphylactic shock—Epirubicin—sarcoma	0.000769	0.00177	CcSEcCtD
Cefadroxil—Convulsion—Doxorubicin—sarcoma	0.000756	0.00174	CcSEcCtD
Cefadroxil—Thrombocytopenia—Epirubicin—sarcoma	0.000753	0.00173	CcSEcCtD
Cefadroxil—Arthralgia—Doxorubicin—sarcoma	0.000743	0.00171	CcSEcCtD
Cefadroxil—Anaphylactic shock—Doxorubicin—sarcoma	0.000712	0.00163	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000701	0.00161	CcSEcCtD
Cefadroxil—Thrombocytopenia—Doxorubicin—sarcoma	0.000697	0.0016	CcSEcCtD
Cefadroxil—Somnolence—Epirubicin—sarcoma	0.000684	0.00157	CcSEcCtD
Cefadroxil—Dyspepsia—Epirubicin—sarcoma	0.000677	0.00156	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Epirubicin—sarcoma	0.000664	0.00153	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000649	0.00149	CcSEcCtD
Cefadroxil—Somnolence—Doxorubicin—sarcoma	0.000633	0.00145	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Epirubicin—sarcoma	0.000629	0.00144	CcSEcCtD
Cefadroxil—Dyspepsia—Doxorubicin—sarcoma	0.000627	0.00144	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000615	0.00141	CcSEcCtD
Cefadroxil—Urticaria—Epirubicin—sarcoma	0.000611	0.0014	CcSEcCtD
Cefadroxil—Abdominal pain—Epirubicin—sarcoma	0.000608	0.0014	CcSEcCtD
Cefadroxil—Body temperature increased—Epirubicin—sarcoma	0.000608	0.0014	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Doxorubicin—sarcoma	0.000582	0.00134	CcSEcCtD
Cefadroxil—Hypersensitivity—Epirubicin—sarcoma	0.000567	0.0013	CcSEcCtD
Cefadroxil—Urticaria—Doxorubicin—sarcoma	0.000566	0.0013	CcSEcCtD
Cefadroxil—Body temperature increased—Doxorubicin—sarcoma	0.000563	0.00129	CcSEcCtD
Cefadroxil—Abdominal pain—Doxorubicin—sarcoma	0.000563	0.00129	CcSEcCtD
Cefadroxil—Asthenia—Epirubicin—sarcoma	0.000552	0.00127	CcSEcCtD
Cefadroxil—Pruritus—Epirubicin—sarcoma	0.000544	0.00125	CcSEcCtD
Cefadroxil—Diarrhoea—Epirubicin—sarcoma	0.000526	0.00121	CcSEcCtD
Cefadroxil—Hypersensitivity—Doxorubicin—sarcoma	0.000525	0.0012	CcSEcCtD
Cefadroxil—Asthenia—Doxorubicin—sarcoma	0.000511	0.00117	CcSEcCtD
Cefadroxil—Dizziness—Epirubicin—sarcoma	0.000509	0.00117	CcSEcCtD
Cefadroxil—Pruritus—Doxorubicin—sarcoma	0.000504	0.00116	CcSEcCtD
Cefadroxil—Vomiting—Epirubicin—sarcoma	0.000489	0.00112	CcSEcCtD
Cefadroxil—Diarrhoea—Doxorubicin—sarcoma	0.000487	0.00112	CcSEcCtD
Cefadroxil—Rash—Epirubicin—sarcoma	0.000485	0.00111	CcSEcCtD
Cefadroxil—Dermatitis—Epirubicin—sarcoma	0.000485	0.00111	CcSEcCtD
Cefadroxil—Headache—Epirubicin—sarcoma	0.000482	0.00111	CcSEcCtD
Cefadroxil—Dizziness—Doxorubicin—sarcoma	0.000471	0.00108	CcSEcCtD
Cefadroxil—Nausea—Epirubicin—sarcoma	0.000457	0.00105	CcSEcCtD
Cefadroxil—Vomiting—Doxorubicin—sarcoma	0.000453	0.00104	CcSEcCtD
Cefadroxil—Rash—Doxorubicin—sarcoma	0.000449	0.00103	CcSEcCtD
Cefadroxil—Dermatitis—Doxorubicin—sarcoma	0.000449	0.00103	CcSEcCtD
Cefadroxil—Headache—Doxorubicin—sarcoma	0.000446	0.00102	CcSEcCtD
Cefadroxil—Nausea—Doxorubicin—sarcoma	0.000423	0.000971	CcSEcCtD
